Chinese patent drug for treating infantile asthma

A technology of Chinese patent medicine and ephedra is applied in the field of Chinese patent medicine for treating pediatric asthma, and can solve the problems of inability to achieve effect, cure rate, poor treatment means and treatment cost, etc.

Inactive Publication Date: 2013-06-12
CHENGDU KECHUANG JIASI TECH
View PDF2 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine often uses salbutamol, Pulmicort, etc. for treatment, and traditional Chinese medicine has commonly used prescriptions such as Tongxuanli Fei Pills, Beimu Zh

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] A Chinese patent medicine for treating infantile asthma, comprising the following components in parts by weight: ephedra 5, almond 8, pinellia 8, asarum 2, schisandra 5, dried ginger 2, winter flower 8, perilla seed 8, white Mustard seeds 8, licorice 5.

[0029] Its preparation method is:

[0030] In parts by weight, get ephedra 5, almond 8, pinellia 8, asarum 2, schisandra 5, dried ginger 2, winter flower 8, perilla seed 8, white mustard seed 8, licorice 5; For impurities, put them in a container and add water to soak the medicinal materials. After 30 minutes, decocted on high heat until boiling, and then simmered for 1 hour. Filter out the medicinal juice and pack it in separate bags. One bag is 200ml. Take one bag each morning and evening.

Embodiment 2

[0032] A Chinese patent medicine for treating infantile asthma, comprising the following components in parts by weight: ephedra 7, almond 12, pinellia 12, asarum 4, schisandra 7, dried ginger 4, winter flower 12, perilla seed 12, white Mustard seeds 12, licorice 7.

[0033] Its preparation method is:

[0034] In parts by weight, take ephedra 7, almond 12, pinellia 12, asarum 4, schisandra 7, dried ginger 4, winter flower 12, perilla seed 12, white mustard seed 12, licorice 7; Mix the medicinal materials, add about 10L of water per kilogram, simmer for 0.5-1 hour, and simmer for 1-2 hours on high heat; pass the decoction through a 150-mesh sieve, and then use a concentrator to concentrate it to a clear paste with a relative density of 1.10-1.20, take 2 / 3. The clear paste is spray-dried at 120°C to obtain clear paste powder, the powder is mixed with the remaining 1 / 3 of the clear paste, and granulated; the granule is dispensed by a granule dispenser to obtain granules.

Embodiment 3

[0036] A Chinese patent medicine for treating infantile asthma, comprising the following components in parts by weight: 6 ephedra, 10 almonds, 10 Pinellia, 3 Asarum, 6 Schisandra, 3 dried ginger, 10 winter flowers, 10 perilla seeds, white Mustard seeds 10, licorice 6.

[0037] Its preparation method is:

[0038] In parts by weight, take ephedra 6, almond 10, pinellia 10, asarum 3, schisandra 6, dried ginger 3, winter flower 10, perilla seed 10, white mustard seed 10, licorice 6; The medicinal materials are mixed, pulverized into 150-180 mesh fine powder with a pulverizer, mixed with appropriate honey, made into a pill machine, dried at low temperature, and packaged to obtain pills.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a Chinese patent drug for treating infantile asthma. The Chinese patent drug comprises, by weight, 5 to 7 parts of ephedra stem, 8 to 12 parts of bitter apricot seed, 8 to 12 parts of pinellia tuber, 2 to 4 parts of manchurian wildginger, 5 to 7 parts of Chinese magnoliavine, 2 to 4 parts of dried ginger, 8 to 12 parts of tussilago flower, 8 to 12 parts of perilla seed, 8 to 12 parts of white mustard seed and 5 to 7 parts of liquorice root. Compared with the prior art, the Chinese patent drug provided by the invention is directed at inherent pathogenic factors of infantile asthma, carries out treatment based on syndrome differentiation and has the advantages of a fast curative effect, low cost, no toxic and side effects, a substantial effect and capacity of treating both manifestation and root cause of infantile asthma.

Description

technical field [0001] The present invention relates to a Chinese patent medicine, more particularly, to a Chinese patent medicine for treating children's asthma. Background technique [0002] Asthma is a common disease in children, clinically characterized by paroxysmal dyspnea, prolonged exhalation, and laryngeal wheezing. Infants and school-age children are the most common. The disease can occur in all seasons, but it is more common in spring and autumn. Fatigue, climate change and inhalation of abnormal odors can induce the disease. Western medicine often uses salbutamol and pumik for treatment. Traditional Chinese medicine has commonly used prescriptions such as Tongxuan Lifei Pill and Beimu Zhike Pill. satisfactory results. The prior art needs a traditional Chinese medicine preparation with good effect to replace the above treatment scheme. SUMMARY OF THE INVENTION [0003] The purpose of the present invention is to provide a Chinese patent medicine for the trea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9068A61P11/06
Inventor 缪家戌
Owner CHENGDU KECHUANG JIASI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap